The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene
Language English Country England, Great Britain Media electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
26861065
PubMed Central
PMC4746830
DOI
10.1186/s12863-016-0346-9
PII: 10.1186/s12863-016-0346-9
Knihovny.cz E-resources
- MeSH
- Neoplastic Syndromes, Hereditary diagnosis genetics MeSH
- Deubiquitinating Enzyme CYLD MeSH
- Phenotype MeSH
- Haplotypes MeSH
- Heterozygote MeSH
- Middle Aged MeSH
- Humans MeSH
- Tumor Suppressor Proteins genetics MeSH
- Skin Neoplasms diagnosis genetics MeSH
- Codon, Nonsense * MeSH
- Pedigree MeSH
- Sequence Analysis, DNA MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Netherlands MeSH
- Austria MeSH
- Spain MeSH
- Names of Substances
- CYLD protein, human MeSH Browser
- Deubiquitinating Enzyme CYLD MeSH
- Tumor Suppressor Proteins MeSH
- Codon, Nonsense * MeSH
BACKGROUND: Multiple familial trichoepithelioma type 1 (MFT1; MIM 601606), a rare monogenic skin disease with autosomal dominant inheritance, is characterized by the development of multiple skin-colored papules on the central area of the face, frequently occurring in the nasolabial area. The disease is associated with various mutations in the cylindromatosis (CYLD; MIM 605018) gene that are also responsible for familial cylindromatosis (FC) and Brooke-Spiegler syndrome (BSS). METHODS: Recently we have identified a Spanish MFT1 pedigree with two affected family members (father and daughter). Direct sequencing of the CYLD gene revealed a worldwide recurrent heterozygous nonsense mutation (c.2272C/T, p.R758X) in the patients. RESULTS: This mutation has already been detected in patients with all three clinical variants - BSS, FC and MFT1 - of the CYLD-mutation spectrum. Haplotype analysis was performed for the Spanish patients with MFT1, Dutch patients with FC and an Austrian patient with BSS, all of whom carry the same heterozygous nonsense p.R758X CYLD mutation. CONCLUSIONS: Our results indicate that this position is a mutational hotspot on the gene and that patients carrying the mutation exhibit high phenotypic diversity.
Department of Clinical Genetics Erasmus MC Rotterdam Netherlands
Department of Dermatology and Allergology University of Szeged Szeged Hungary
Department of Medical Genetics University of Szeged 4 Somogyi B H 6720 Szeged Hungary
MTA SZTE Dermatological Research Group University of Szeged Szeged Hungary
Unit of Molecular Genetics Bioptical Laboratory Pilsen Czech Republic
See more in PubMed
Biggs PJ, Wooster R, Ford D, Chapman P, Mangion J, Quirk Y, et al. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat. Genet. 1995;11:441–443. doi: 10.1038/ng1295-441. PubMed DOI
Biggs PJ, Chapman P, Lakhani SR, Burn J, Stratton MR. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas. Oncogene. 1996;12:1375–1377. PubMed
Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000;25:160–165. doi: 10.1038/76006. PubMed DOI
Fenske C, Banerjee P, Holden C, Carter N. Brooke-Spiegler syndrome locus assigned to 16q12-q13. J. Invest. Dermatol. 2000;114:1057–1058. doi: 10.1046/j.1523-1747.2000.00960.x. PubMed DOI
Gutierrez PP, Eggermann T, Holler D, Jugert FK, Beermann T, Grussendorf-Conen E-I, et al. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J. Invest. Dermatol. 2002;119:527–531. doi: 10.1046/j.1523-1747.2002.01839.x. PubMed DOI
Hu G, Onder M, Gill M, Aksakal B, Oztas M, Gurer MA, et al. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome. J. Invest. Dermatol. 2003;121:732–734. doi: 10.1046/j.1523-1747.2003.12514.x. PubMed DOI
Gerretsen AL, Beemer FA, Deenstra W, Hennekam FAM, van Vloten WA. Familial cutaneous cylindromas: investigations in five generations of a family. J. Am. Acad. Dermatol. 1995;33:199–206. doi: 10.1016/0190-9622(95)90234-1. PubMed DOI
Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-kappa-B signalling by deubiquitination. Nature. 2003;424:801–805. doi: 10.1038/nature01802. PubMed DOI
Van den Ouweland AM, Elfferich P, Lamping R, van de Graaf R, van Veghel-Plandsoen MM, Franken SM, et al. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis. Fam Cancer. 2011;10:127–132. doi: 10.1007/s10689-010-9393-y. PubMed DOI PMC
Grossmann P, Vanecek T, Steiner P, Kacerovska D, Spagnolo DV, Cribier B, et al. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Am J Dermatopathol. 2013;35:34–44. doi: 10.1097/DAD.0b013e31824e7658. PubMed DOI
Kazakov DV, Thoma-Uszynski S, Vanecek T, Kacerovska D, Grossmann P, Michal M. A case of Brooke-Spiegler syndrome with a novel germline deep intronic mutation in the CYLD gene leading to intronic exonization, diverse somatic mutations, and unusual histology. Am J Dermatopathol. 2009;31:664–673. doi: 10.1097/DAD.0b013e3181a05dad. PubMed DOI
Zhang G, Huang Y, Yan K, Li W, Fan X, Liang Y, et al. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene. Exp Dermatol. 2006;15:966–970. doi: 10.1111/j.1600-0625.2006.00501.x. PubMed DOI
Oiso N, Mizuno N, Fukai K, Nakagawa K, Ishii M. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene. Br J Dermatol. 2004;151:1084–1086. doi: 10.1111/j.1365-2133.2004.06231.x. PubMed DOI
Kazakov DV, Vanecek T, Zelger B, Carlson JA, Spagnolo DV, Schaller J, et al. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients. Am J Dermatopathol. 2011;33:251–265. doi: 10.1097/DAD.0b013e3181f7d373. PubMed DOI
Nagy N, Rajan N, Farkas K, Kinyó A, Kemény L, Széll M. A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds. Acta Derm Venereol. 2013;93:743–745. doi: 10.2340/00015555-1590. PubMed DOI PMC